Categories for News

Free community webinar about MacTel

November 14, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database.  ... View Article

Neurotech Provides Update on BLA for NT-501 as a Treatment for Macular Telangiectasia Type 2 (MacTel)

LMRI would like to share the following press release from Neurotech Pharmaceuticals about the BLA for NT-501 as a treatement... View Article

Neurotech Receives Priority Review of Biologics License Application for NT-501 as a Treatment for Macular Telangiectasia Type 2

June 20, 2024 LMRI would like to share the news that Neurotech has received Priority Review of Biologics License Application... View Article

What To Expect in a MacTel Imaging Exam

April 29, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database.  ... View Article

MacTel SAFE Study

March 6, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database.  ... View Article

MacTel Project 2023 Annual Meeting Summary

February 6, 2024 The following information was sent out via email to people who registered in the LMRI Contact Database.  ... View Article

Positive Phase 3 Topline Results Announced for NT-501 Implant in MacTel

November 2, 2022 Neurotech Pharmaceuticals, Inc. announces positive Phase 3 topline results for NT-501 implant in macular telangiectaisa type 2... View Article

MacTel Project 2021 Update

LOWY MEDICAL RESEARCH INSTITUTE – LMRI This past year has surely been an interesting and challenging one.  We hope that... View Article

CNTF Phase 3 Trial Enrollment Complete

September 21, 2020 Neurotech Pharmaceuticals, with support from the Lowy Medical Research Institute, is conducting a Phase 3 clinical trial... View Article

CNTF Clinical Trials: COVID-19 Update

March 24, 2020 The rapid spread of COVID-19 has disrupted many standard clinical operations, including the LMRI/Neurotech Phase 1, 2,... View Article